Assessment of Differential Renal Function by CT in Living Donors
NCT ID: NCT02820376
Last Updated: 2020-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2016-06-28
2018-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Living Renal Donor MRI Study
NCT01280851
Study of Prospective Assessment of Living Kidney Donors: Pre and Post Donation
NCT00813579
Kidney Disease and Ultrasound Imaging
NCT02201537
Impact of Preemptive Living Donor Renal Transplantation on Quality of Life , Occupational Rehabilitation and Societal Participation of Transplant Recipients
NCT02893475
Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.
NCT06047106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All patients
Differential renal function assessment by 4D CT:
All patients will undergo both CT and SPECT assessment of differential renal function; each patient will be his own comparator
Differential renal function assessment by 4D CT
Low dose 4D (perfusion) renal acquisition after injection of iodinated contrast medium (ICM) (13 passes every 3 seconds, 3 passes every 10 seconds); estimated additional DLP 400 mGy.cm No additional contrast medium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Differential renal function assessment by 4D CT
Low dose 4D (perfusion) renal acquisition after injection of iodinated contrast medium (ICM) (13 passes every 3 seconds, 3 passes every 10 seconds); estimated additional DLP 400 mGy.cm No additional contrast medium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mandatory enrollment in a health security plan (French Social Security)
* Subject having signed an informed consent
Exclusion Criteria
* Subjects with an abnormal urinary tract (unique kidney, ectopic kidney, horseshoe kidney)
* Subjets under a legal protection measure
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
University of Lorraine
OTHER
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Damien Mandry, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
CHRU Nancy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSS 2016 / DOVISCAN - MANDRY /
Identifier Type: OTHER
Identifier Source: secondary_id
2016-A00543-48
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.